Clinical Trial Update: A Study With Mirabegron 50 mg and 25 mg in Chinese Participants With Overactive Bladder [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating mirabegron at 50 mg and 25 mg in Chinese participants with overactive bladder has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Urge Incontinence

Drugs mentioned

• Mirabegron (mirabegron)

Snippet

Sponsor: Astellas Pharma China, Inc. | Conditions: Urge Incontinence, Overactive Bladder (OAB) | Phase 4 | Status: COMPLETED | Results posted: 2023-03-29